ARS Pharmaceuticals
SPRY
SPRY
68 hedge funds and large institutions have $1.21B invested in ARS Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
68
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$59.9M | |
| 2 | +$45.2M | |
| 3 | +$36.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$8.96M |
Top Sellers
| 1 | -$9.22M | |
| 2 | -$7.64M | |
| 3 | -$6.4M | |
| 4 |
Millennium Management
New York
|
-$5.64M |
| 5 |
Goldman Sachs
New York
|
-$4.07M |